| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility
|
Crawford, E. David
|
|
2017
|
|
5 |
p. 319-333
|
artikel
|
| 2 |
Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential
|
Peddi, Parvin F.
|
|
2014
|
|
5 |
p. 202-209
|
artikel
|
| 3 |
Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?
|
Dirix, L.Y.
|
|
2010
|
|
5 |
p. 331-342
|
artikel
|
| 4 |
Cancer-induced muscle wasting: latest findings in prevention and treatment
|
Aversa, Zaira
|
|
2017
|
|
5 |
p. 369-382
|
artikel
|
| 5 |
Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective
|
Takeda, Koji
|
|
2013
|
|
5 |
p. 301-311
|
artikel
|
| 6 |
Clinical development of S-1 for non-small cell lung cancer: a Japanese perspective
|
Takeda, Koji
|
|
2013
|
|
5 |
p. 301-311
|
artikel
|
| 7 |
Concepts and targets in triple-negative breast cancer: recent results and clinical implications
|
Saha, Poornima
|
|
2016
|
|
5 |
p. 351-359
|
artikel
|
| 8 |
Corrigendum
|
|
|
2013
|
|
5 |
p. 312
|
artikel
|
| 9 |
Corrigendum
|
|
|
2013
|
|
5 |
p. 312-312
|
artikel
|
| 10 |
Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors
|
Kee, Damien
|
|
2012
|
|
5 |
p. 255-270
|
artikel
|
| 11 |
Docetaxel in prostate cancer: a familiar face as the new standard in a hormone-sensitive setting
|
Puente, Javier
|
|
2017
|
|
5 |
p. 307-318
|
artikel
|
| 12 |
Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?
|
Dréanic, Johann
|
|
2016
|
|
5 |
p. 383-387
|
artikel
|
| 13 |
Exosome-mediated drug resistance in cancer: the near future is here
|
Giallombardo, Marco
|
|
2016
|
|
5 |
p. 320-322
|
artikel
|
| 14 |
Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness
|
Silapunt, Sirunya
|
|
2016
|
|
5 |
p. 375-382
|
artikel
|
| 15 |
Highlights of the 2nd European Lung Cancer Conference
|
Shepherd, Frances A.
|
|
2010
|
|
5 |
p. 297-299
|
artikel
|
| 16 |
History and current state of immunotherapy in glioma and brain metastasis
|
McGranahan, Tresa
|
|
2017
|
|
5 |
p. 347-368
|
artikel
|
| 17 |
Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy
|
Augereau, Paule
|
|
2017
|
|
5 |
p. 335-346
|
artikel
|
| 18 |
Neoadjuvant therapy of early stage human epidermal growth factor receptor 2 positive breast cancer: latest evidence and clinical implications
|
Pernas Simon, Sonia
|
|
2014
|
|
5 |
p. 210-221
|
artikel
|
| 19 |
Neratinib in HER-2-positive breast cancer: results to date and clinical usefulness
|
Chan, Arlene
|
|
2016
|
|
5 |
p. 339-350
|
artikel
|
| 20 |
Neurokinin-1 inhibitors in the prevention of nausea and vomiting from highly emetogenic chemotherapy: a network meta-analysis
|
Abdel-Rahman, Omar
|
|
2016
|
|
5 |
p. 396-406
|
artikel
|
| 21 |
New combinations and immunotherapies for melanoma: latest evidence and clinical utility
|
Menzies, Alexander M.
|
|
2013
|
|
5 |
p. 278-285
|
artikel
|
| 22 |
New combinations and immunotherapies for melanoma: latest evidence and clinical utility
|
Menzies, Alexander M.
|
|
2013
|
|
5 |
p. 278-285
|
artikel
|
| 23 |
Novel agents in development for advanced non-small cell lung cancer
|
Stinchcombe, Thomas E.
|
|
2014
|
|
5 |
p. 240-253
|
artikel
|
| 24 |
Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer
|
Dimou, Anastasios
|
|
2012
|
|
5 |
p. 271-279
|
artikel
|
| 25 |
Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy
|
Ferraro, Danielle
|
|
2014
|
|
5 |
p. 222-228
|
artikel
|
| 26 |
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors
|
Verzoni, Elena
|
|
2016
|
|
5 |
p. 323-330
|
artikel
|
| 27 |
Sonic hedgehog pathway expression in non-small cell lung cancer
|
Savani, Malvi
|
|
2012
|
|
5 |
p. 225-233
|
artikel
|
| 28 |
Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond
|
Migali, Cristina
|
|
2016
|
|
5 |
p. 360-374
|
artikel
|
| 29 |
Targeting intratumoral androgens: statins and beyond
|
Schweizer, Michael T.
|
|
2016
|
|
5 |
p. 388-395
|
artikel
|
| 30 |
The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations
|
Okamoto, Isamu
|
|
2010
|
|
5 |
p. 301-307
|
artikel
|
| 31 |
The potential for trastuzumab emtansine in human epidermal growth factor receptor 2 positive metastatic breast cancer: latest evidence and ongoing studies
|
Hurvitz, Sara A.
|
|
2012
|
|
5 |
p. 235-245
|
artikel
|
| 32 |
Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer
|
Zeller, Constanze
|
|
2010
|
|
5 |
p. 319-329
|
artikel
|
| 33 |
Therapeutic options in older patients with metastatic non-small cell lung cancer
|
Quoix, Elisabeth
|
|
2012
|
|
5 |
p. 247-254
|
artikel
|
| 34 |
The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events
|
Cummins, Meredith
|
|
2013
|
|
5 |
p. 286-300
|
artikel
|
| 35 |
The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events
|
Cummins, Meredith
|
|
2013
|
|
5 |
p. 286-300
|
artikel
|
| 36 |
Treatment options in recurrent ovarian cancer: latest evidence and clinical potential
|
Luvero, Daniela
|
|
2014
|
|
5 |
p. 229-239
|
artikel
|
| 37 |
Ultrasound-guided radiofrequency ablation for cT1a renal masses in poor surgical candidates: mid-term, single-center outcomes
|
Zachos, Ioannis
|
|
2016
|
|
5 |
p. 331-338
|
artikel
|
| 38 |
Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity
|
Chong, G.
|
|
2010
|
|
5 |
p. 309-317
|
artikel
|
Tijdschrift beschrijving